Home Market News AARP weighs in on Merck case challenging Medicare drug negotiation

AARP weighs in on Merck case challenging Medicare drug negotiation

0
AARP weighs in on Merck case challenging Medicare drug negotiation
Stop RX Greed

Don Juan Moore/Getty Photos Leisure

AARP has submitted an amicus curiae temporary with a federal courtroom in Washington, DC, in a case filed by Merck (NYSE:MRK) that’s difficult Medicare’s capability to barter prescription drug costs.

The group is arguing that seniors could be harmed